Discontinuation of the Development of a regenerative 스포츠 베팅 게임 Medicine Product (CL2020) Using Muse Cells
February 14, 2023
The Mitsubishi Chemical Group ("the Group") has decided to discontinue the development of a regenerative medicine product (CL2020) using Muse 스포츠 베팅 게임*.
The Group has been actively developing and investing in the research and development of regenerative medicine products using Muse Cells since 2015. However, after comprehensive and careful consideration of the latest clinical developments, timelines f스포츠 베팅 게임 commercialization, and its pharmaceutical business strategy going f스포츠 베팅 게임ward, the Group has decided to discontinue the development of CL2020.
* Muse 스포츠 베팅 게임: Multilineage-differentiating Stress-Enduring 스포츠 베팅 게임
The Group has been actively developing and investing in the research and development of regenerative medicine products using Muse Cells since 2015. However, after comprehensive and careful consideration of the latest clinical developments, timelines f스포츠 베팅 게임 commercialization, and its pharmaceutical business strategy going f스포츠 베팅 게임ward, the Group has decided to discontinue the development of CL2020.
* Muse 스포츠 베팅 게임: Multilineage-differentiating Stress-Enduring 스포츠 베팅 게임
